Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume:4683.89
3.71
-0.06  (-1.59%)
Announcement & Circular
12-09
2015
ANNOUNCEMENT - ESTABLISHMENT OF A SUBSIDIARY
12-04
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2015
12-03
2015
ANNOUNCEMENT - APPROVAL FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR LEVETIRACETAM EXTENDED RELEASE TABLET
11-05
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2015
10-07
2015
THE FDA CONFIRMED NO ADDITIONAL CLINICAL TRIALS ARE NEEDED FOR THE NDA SUBMISSION FOR LY03004 IN THE U.S.
10-02
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2015
09-30
2015
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
09-29
2015
Interim Report 2015
09-07
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2015
08-30
2015
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015
46
47
48
49
50